The Deakin/Graeff hypothesis: Focus on serotonergic inhibition of panic

Neuroscience and Biobehavioral Reviews

Volumn 46, Issue P3, 2014, Pages 379-396

  Paul, Evan D ^a   Johnson, Philip L ^a,b   Shekhar, Anantha ^a,b   Lowry, Christopher A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid sensing ion channels; Amygdala; Carbon dioxide; Corticotropin releasing hormone; Dorsal raphe nucleus; Panic attack; Panic disorder; Periaqueductal gray; Serotonin; Sodium lactate; Stress; TASK

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; ACID SENSING ION CHANNEL; ANGIOTENSIN II; ANTIDEPRESSANT AGENT; BUSPIRONE; CARBON DIOXIDE; CLOMIPRAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; FLUOXETINE; IMIPRAMINE; LACTATE SODIUM; MONOAMINE OXIDASE INHIBITOR; OREXIN; PAROXETINE; PHENELZINE; PINDOLOL; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 2A AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ANXIETY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG POTENTIATION; ESCAPE BEHAVIOR; FACILITATION; FEAR; HUMAN; HYPERVENTILATION; LONG TERM CARE; NERVE PROJECTION; NEUROMODULATION; NONHUMAN; PANIC; PATHOPHYSIOLOGY; PERIAQUEDUCTAL GRAY MATTER; PROTEIN EXPRESSION; REVIEW; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SUFFOCATION; TRANQUILIZING ACTIVITY; ANIMAL; BRAIN; COMPLICATION; INHIBITION (PSYCHOLOGY); METABOLISM; PANIC DISORDER; PATHOLOGY; PHYSIOLOGY; RESPIRATION DISORDERS;

ANIMALS; BRAIN; HUMANS; INHIBITION (PSYCHOLOGY); PANIC; PANIC DISORDER; RESPIRATION DISORDERS; SEROTONERGIC NEURONS;

EID: 84911364315     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.03.010     Document Type: Review

References (288)

1. Abrams J.K., Johnson P.L., Hay-Schmidt A., Mikkelsen J.D., Shekhar A., Lowry C.A. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 2005, 133:983-997.
2. Adolphs R. The biology of fear. Curr. Biol. 2013, 23:R79-R93.
3. Adolphs R., Tranel D. Emotion recognition and the human amygdala. The Amygdala 2000, 587-630. Oxford University Press, New York. J.P. Aggleton (Ed.).
4. Albrecht D., Nitschke T., Von Bohlen Und H.O. Various effects of angiotensin II on amygdaloid neuronal activity in normotensive control and hypertensive transgenic [TGR(mREN-2)27] rats. FASEB J. 2000, 14:925-931.
5. Amaral D.G., Price J.L. Amygdalo-cortical projections in the monkey (Macaca fascicularis). J. Comp. Neurol. 1984, 230:465-496.
6. Amaral J.M., Spadaro P.T., Pereira V.M., Silva A.C., Nardi A.E. The carbon dioxide challenge test in panic disorder: a systematic review of preclinical and clinical research. Rev. Bras. Psiquiatr. 2013, 35:318-331.
7. Amat J., Tamblyn J.P., Paul E.D., Bland S.T., Amat P., Foster A.C., Watkins L.R., Maier S.F. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 2004, 129:509-519.
8. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1980, American Psychiatric Association, Washington, DC. 3rd ed.
9. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, Arlington, VA. 5th ed.
10. Angst J. Panic disorder: history and epidemiology. Eur. Psychiatry 1998, 13(Suppl. 2):51s-55s.
11. Asami T., Yamasue H., Hayano F., Nakamura M., Uehara K., Otsuka T., Roppongi T., Nihashi N., Inoue T., Hirayasu Y. Sexually dimorphic gray matter volume reduction in patients with panic disorder. Psychiatry Res. 2009, 173:128-134.
12. Battaglia M., Bertella S., Politi E., Bernardeschi L., Perna G., Gabriele A., Bellodi L. Age at onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. Am. J. Psychiatry 1995, 152:1362-1364.
13. Bechara A., Tranel D., Damasio H., Adolphs R., Rockland C., Damasio A.R. Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science 1995, 269:1115-1118.
14. Beckett S., Marsden C.A. The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour. J. Psychopharmacol. 1997, 11:35-40.
15. Beckett S.R., Lawrence A.J., Marsden C.A., Marshall P.W. Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray. Psychopharmacology (Berl.) 1992, 108:110-114.
16. Bell C.J., Nutt D.J. Serotonin and panic. Br. J. Psychiatry 1998, 172:465-471.
17. Berridge C.W., Espana R.A., Vittoz N.M. Hypocretin/orexin in arousal and stress. Brain Res. 2010, 1314:91-102.
18. Berridge C.W., Mitton E., Clark W., Roth R.H. Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse 1999, 32:187-197.
19. Biederman J., Faraone S.V., Hirshfeld-Becker D.R., Friedman D., Robin J.A., Rosenbaum J.F. Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression. Am. J. Psychiatry 2001, 158:49-57.
20. Biederman J., Petty C.R., Faraone S.V., Hirshfeld-Becker D.R., Henin A., Brauer L., Kaufman B., Rosenbaum J.F. Antecedents to panic disorder in nonreferred adults. J. Clin. Psychiatry 2006, 67:1179-1186.
21. Bienvenu O.J., Onyike C.U., Stein M.B., Chen L.S., Samuels J., Nestadt G., Eaton W.W. Agoraphobia in adults: incidence and longitudinal relationship with panic. Br. J. Psychiatry 2006, 188:432-438.
22. Bijlsma E.Y., van Leeuwen M.L., Westphal K.G., Olivier B., Groenink L. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex. Neuroscience 2011, 173:82-92.
23. Bisetti A., Cvetkovic V., Serafin M., Bayer L., Machard D., Jones B.E., Muhlethaler M. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 2006, 142:999-1004.
24. Blanchard D.C., Griebel G., Blanchard R.J. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 2001, 25:205-218.
25. Blanchard R.J., Blanchard D.C. Attack and defense in rodents as ethoexperimental models for the study of emotion. Prog. Neuropsychopharmacol. Biol. Psychiatry 1989, 13(Suppl.):S3-S14.
26. Blanchard R.J., Flannelly K.J., Blanchard D.C. Defensive behavior of laboratory and wild Rattus norvegicus. J. Comp. Psychol. 1986, 100:101-107.
27. Blanchard R.J., Nikulina J.N., Sakai R.R., McKittrick C., McEwen B., Blanchard D.C. Behavioral and endocrine change following chronic predatory stress. Physiol. Behav. 1998, 63:561-569.
28. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., de L.L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19168-19173.
29. Bradley S.R., Pieribone V.A., Wang W., Severson C.A., Jacobs R.A., Richerson G.B. Chemosensitive serotonergic neurons are closely associated with large medullary arteries. Nat. Neurosci. 2002, 5:401-402.
30. Bradwejn J., Koszycki D., Payeur R., Bourin M., Borthwick H. Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings. Am. J. Psychiatry 1992, 149:962-964.
31. Bradwejn J., Koszycki D., Shriqui C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch. Gen. Psychiatry 1991, 48:603-610.
32. Brandao M.L., Lopez-Garcia J.A., Graeff F.G., Roberts M.H. Electrophysiological evidence for excitatory 5-HT2 and depressant 5-HT1A receptors on neurones of the rat midbrain tectum. Brain Res. 1991, 556:259-266.
33. Brandao M.L., Zanoveli J.M., Ruiz-Martinez R.C., Oliveira L.C., Landeira-Fernandez J. Different patterns of freezing behavior organized in the periaqueductal gray of rats: association with different types of anxiety. Behav. Brain Res. 2008, 188:1-13.
34. Brannan S., Liotti M., Egan G., Shade R., Madden L., Robillard R., Abplanalp B., Stofer K., Denton D., Fox P.T. Neuroimaging of cerebral activations and deactivations associated with hypercapnia and hunger for air. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2029-2034.
35. Brown R.E., Sergeeva O., Eriksson K.S., Haas H.L. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 2001, 40:457-459.
36. Brown R.E., Sergeeva O.A., Eriksson K.S., Haas H.L. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci. 2002, 22:8850-8859.
37. 2. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16354-16359.
38. Buckler K.J., Turner P.J. Oxygen sensitivity of mitochondrial function in rat arterial chemoreceptor cells. J. Physiol. (Lond.) 2013, 591:3549-3563.
39. Cameron A.A., Khan I.A., Westlund K.N., Cliffer K.D., Willis W.D. The efferent projections of the periaqueductal gray in the rat: a Phaseolus vulgaris-leucoagglutinin study. I. Ascending projections. J. Comp. Neurol. 1995, 351:568-584.
40. Cameron A.A., Khan I.A., Westlund K.N., Willis W.D. The efferent projections of the periaqueductal gray in the rat: a Phaseolus vulgaris-leucoagglutinin study. II. Descending projections. J. Comp. Neurol. 1995, 351:585-601.
41. Carrive P. Orexin, orexin receptor antagonists and central cardiovascular control. Front. Neurosci. 2013, 7:257.
42. Cassell M.D., Gray T.S., Kiss J.Z. Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J. Comp. Neurol. 1986, 246:478-499.
43. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 1995, 15:6340-6350.
44. Charney D.S., Heninger G.R., Jatlow P.I. Increased anxiogenic effects of caffeine in panic disorders. Arch. Gen. Psychiatry 1985, 42:233-243.
45. Charney D.S., Woods S.W., Goodman W.K., Heninger G.R. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am. J. Psychiatry 1987, 144:1030-1036.
46. Choi D.C., Nguyen M.M., Tamashiro K.L., Ma L.Y., Sakai R.R., Herman J.P. Chronic social stress in the visible burrow system modulates stress-related gene expression in the bed nucleus of the stria terminalis. Physiol. Behav. 2006, 89:301-310.
47. Cluderay J.E., Harrison D.C., Hervieu G.J. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul. Pept. 2002, 104:131-144.
48. Connor K.M., Davidson J.R. Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biol. Psychiatry 1998, 44:1286-1294.
49. Corcoran A.E., Richerson G.B., Harris M.B. Serotonergic mechanisms are necessary for central respiratory chemoresponsiveness in situ. Respir. Physiol. Neurobiol. 2013, 186:214-220.
50. Cordero M.I., Merino J.J., Sandi C. Correlational relationship between shock intensity and corticosterone secretion on the establishment and subsequent expression of contextual fear conditioning. Behav. Neurosci. 1998, 112:885-891.
51. Coryell M.W., Wunsch A.M., Haenfler J.M., Allen J.E., McBride J.L., Davidson B.L., Wemmie J.A. Restoring acid-sensing ion channel-1a in the amygdala of knock-out mice rescues fear memory but not unconditioned fear responses. J. Neurosci. 2008, 28:13738-13741.
52. Coryell M.W., Ziemann A.E., Westmoreland P.J., Haenfler J.M., Kurjakovic Z., Zha X.M., Price M., Schnizler M.K., Wemmie J.A. Targeting ASIC1a reduces innate fear and alters neuronal activity in the fear circuit. Biol. Psychiatry 2007, 62:1140-1148.
53. Cox G.E., Jordan D., Paton J.F., Spyer K.M., Wood L.M. Cardiovascular and phrenic nerve responses to stimulation of the amygdala central nucleus in the anaesthetized rabbit. J. Physiol. 1987, 389:541-556.
54. Craske M.G., Kircanski K., Epstein A., Wittchen H.U., Pine D.S., Lewis-Fernandez R., Hinton D. Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V. Depress. Anxiety 2010, 27:93-112.
55. Crawford L.K., Craige C.P., Beck S.G. Increased intrinsic excitability of lateral wing serotonin neurons of the dorsal raphe: a mechanism for selective activation in stress circuits. J. Neurophysiol. 2010, 103:2652-2663.
56. 2 sensitivity induced by gene-by-environment interplay. PLoS ONE 2011, 6:e18637.
57. Daugherty W.P., Corley K.C., Phan T.H., Boadle-Biber M.C. Further studies on the activation of rat median raphe serotonergic neurons by inescapable sound stress. Brain Res. 2001, 923:103-111.
58. Davis M. Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes. Neurosci. Biobehav. Rev. 1980, 4:241-263.
59. Davis M., Shi C. The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?. Ann. N. Y. Acad. Sci. 1999, 877:281-291.
60. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010, 35:105-135.
61. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., Campeau S. Differential expression of 5HT-1A, alpha(1b) adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol. 2004, 474:364-378.
62. de Bortoli V.C., Nogueira R.L., Zangrossi H. Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT (2A) receptors in the rat dorsal periaqueductal gray. Psychopharmacology (Berl.) 2008, 198:341-349.
63. de Bortoli V.C., Nogueira R.L., Zangrossi H. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray. Psychopharmacology (Berl.) 2006, 183:422-428.
64. de Lecea L. A decade of hypocretins: past, present and future of the neurobiology of arousal. Acta Physiol. (Oxf.) 2010, 198:203-208.
65. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., Van Den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:322-327.
66. de Oliveira S.T., de Bortoli V.C., Zangrossi H. Serotonin-2A receptor regulation of panic-like behavior in the rat dorsal periaqueductal gray matter: the role of GABA. Psychopharmacology (Berl.) 2011, 218:725-732.
67. de Paula Soares V., Zangrossi H. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze. Brain Res. Bull. 2004, 64:181-188.
68. De Souza E.B., Insel T.R., Perrin M.H., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 1985, 5:3189-3203.
69. Deakin J.F.W., Graeff F.G. 5-HT and mechanisms of defence. J. Psychopharmacol. (Oxf.) 1991, 5:305-315.
70. Del-Ben C.M., Graeff F.G. Panic disorder: is the PAG involved?. Neural Plast. 2009 2009, 108135.
71. Dilts R.P., Boadle-Biber M.C. Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound. Neurosci. Lett. 1995, 199:78-80.
72. Dong H.W., Petrovich G.D., Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Brain Res. Rev. 2001, 38:192-246.
73. Donner N.C., Johnson P.L., Fitz S.D., Kellen K.E., Shekhar A., Lowry C.A. Elevated tph2 mRNA expression in a rat model of chronic anxiety. Depress. Anxiety 2012, 29:307-319.
74. Dumont F.S., Biancardi V., Kinkead R. Hypercapnic ventilatory response of anesthetized female rats subjected to neonatal maternal separation: insight into the origins of panic attacks?. Respir. Physiol. Neurobiol. 2011, 175:288-295.
75. Duvarci S. Central amygdala activity during fear conditioning. J. Neurosci. 2011, 31:289-294.
76. Dwyer J.M., Rizzo S.J., Neal S.J., Lin Q., Jow F., Arias R.L., Rosenzweig-Lipson S., Dunlop J., Beyer C.E. Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models. Psychopharmacology (Berl.) 2009, 203:41-52.
77. Emsley R.A., Paster L. Lipoid proteinosis presenting with neuropsychiatric manifestations. J. Neurol. Neurosurg. Psychiatry 1985, 48:1290-1292.
78. + currents: two-pore domain potassium channels. Physiol. Rev. 2010, 90:559-605.
79. Espana R.A., Valentino R.J., Berridge C.W. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 2003, 121:201-217.
80. Evans A.K., Heerkens J.L., Lowry C.A. Acoustic stimulation in vivo and corticotropin-releasing factor in vitro increase tryptophan hydroxylase activity in the rat caudal dorsal raphe nucleus. Neurosci. Lett. 2009, 455:36-41.
81. Fanselow M.S. Neural organization of the defensive behavior system responsible for fear. Psychon. Bull. Rev. 1994, 1:429-438.
82. Feinstein J.S., Adolphs R., Damasio A., Tranel D. The human amygdala and the induction and experience of fear. Curr. Biol. 2011, 21:34-38.
83. Feinstein J.S., Buzza C., Hurlemann R., Follmer R.L., Dahdaleh N.S., Coryell W.H., Welsh M.J., Tranel D., Wemmie J.A. Fear and panic in humans with bilateral amygdala damage. Nat. Neurosci. 2013.
84. Fernandez de Molina A., Hunsperger R.W. Central representation of affective reactions in forebrain and brain stem: electrical stimulation of amygdala, stria terminalis, and adjacent structures. J. Physiol. (Lond.) 1959, 145:251-265.
85. Fernandez de Molina A., Hunsperger R.W. Organization of the subcortical system governing defence and flight reactions in the cat. J. Physiol. (Lond.) 1962, 160:200-213.
86. Forster G.L., Feng N., Watt M.J., Korzan W.J., Mouw N.J., Summers C.H., Renner K.J. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience 2006, 141:1047-1055.
87. Forster G.L., Pringle R.B., Mouw N.J., Vuong S.M., Watt M.J., Burke A.R., Lowry C.A., Summers C.H., Renner K.J. Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur. J. Neurol. 2008, 28:299-310.
88. Fox J.H., Lowry C.A. Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior. Front. Neurosci. 2013, 7:169.
89. Franchini K.G., Krieger E.M. Cardiovascular responses of conscious rats to carotid body chemoreceptor stimulation by intravenous KCN. J. Auton. Nerv. Syst. 1993, 42:63-69.
90. Franchini K.G., Oliveira V.L., Krieger E.M. Hemodynamics of chemoreflex activation in unanesthetized rats. Hypertension 1997, 30:699-703.
91. Funk D., Li Z., Le A.D. Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience 2006, 138:235-243.
92. Gardner K.L., Hale M.W., Oldfield S., Lightman S.L., Plotsky P.M., Lowry C.A. Adverse experience during early life and adulthood interact to elevate tph2 mRNA expression in serotonergic neurons within the dorsal raphe nucleus. Neuroscience 2009, 163:991-1001.
93. Gardner K.L., Thrivikraman K.V., Lightman S.L., Plotsky P.M., Lowry C.A. Early life experience alters behavior during social defeat: focus on serotonergic systems. Neuroscience 2005, 136:181-191.
94. Gater R., Tansella M., Korten A., Tiemens B.G., Mavreas V.G., Olatawura M.O. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care. Arch. Gen. Psychiatry 1998, 55:405-413.
95. Genest S.E., Gulemetova R., Laforest S., Drolet G., Kinkead R. Neonatal maternal separation induces sex-specific augmentation of the hypercapnic ventilatory response in awake rat. J. Appl. Physiol. 2007, 102:1416-1421.
96. Goodwin R.D., Faravelli C., Rosi S., Cosci F., Truglia E., de G.R., Wittchen H.U. The epidemiology of panic disorder and agoraphobia in Europe. Eur. Neuropsychopharmacol. 2005, 15:435-443.
97. Gorman J.M., Askanazi J., Liebowitz M.R., Fyer A.J., Stein J., Kinney J.M., Klein D.F. Response to hyperventilation in a group of patients with panic disorder. Am. J. Psychiatry 1984, 141:857-861.
98. Gorman J.M., Battista D., Goetz R.R., Dillon D.J., Liebowitz M.R., Fyer A.J., Kahn J.P., Sandberg D., Klein D.F. A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. Arch. Gen. Psychiatry 1989, 46:145-150.
99. Gorman J.M., Kent J.M., Sullivan G.M., Coplan J.D. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 2000, 157:493-505.
100. Gorman J.M., Liebowitz M.R., Fyer A.J., Stein J. A neuroanatomical hypothesis for panic disorder. Am. J. Psychiatry 1989, 146:148-161.
101. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neurosci. Biobehav. Rev. 2004, 28:239-259.
102. Graeff F.G., Guimaraes F.S., De Andrade T.G., Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. 1996, 54:129-141.
103. Gray T.S., Magnuson D.J. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 1992, 13:451-460.
104. Greco M.A., Shiromani P.J. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res. Mol. Brain Res. 2001, 88:176-182.
105. Griebel G., Blanchard D.C., Blanchard R.J. Predator-elicited flight responses in Swiss-Webster mice: an experimental model of panic attacks. Prog. Neuropsychopharmacol. Biol. Psychiatry 1996, 20:185-205.
106. Griez E., Schruers K. Experimental pathophysiology of panic. J. Psychosom. Res. 1998, 45:493-503.
107. Griffiths J.L., Lovick T.A. Co-localization of 5-HT 2A-receptor- and GABA-immunoreactivity in neurones in the periaqueductal grey matter of the rat. Neurosci. Lett. 2002, 326:151-154.
108. Guo J.D., Hammack S.E., Hazra R., Levita L., Rainnie D.G. Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes. Neuroscience 2009, 164:1776-1793.
109. Guttmacher L.B., Murphy D.L., Insel T.R. Pharmacologic models of anxiety. Compr. Psychiatry 1983, 24:312-326.
110. Guyenet P.G., Abbott S.B., Stornetta R.L. The respiratory chemoreception conundrum: light at the end of the tunnel?. Brain Res. 2013, 1511:126-137.
111. Guyenet P.G., Stornetta R.L., Bayliss D.A. Retrotrapezoid nucleus and central chemoreception. J. Physiol. (Lond.) 2008, 586:2043-2048.
112. Hale M.W., Lowry C.A. Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits. Psychopharmacology (Berl.) 2011, 213:243-264.
113. Hammack S.E., Guo J.D., Hazra R., Dabrowska J., Myers K.M., Rainnie D.G. The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1309-1320.
114. Hayano F., Nakamura M., Asami T., Uehara K., Yoshida T., Roppongi T., Otsuka T., Inoue T., Hirayasu Y. Smaller amygdala is associated with anxiety in patients with panic disorder. Psychiatry Clin. Neurosci. 2009, 63:266-276.
115. Hayward L.F., Von Reitzenstein M. c-Fos expression in the midbrain periaqueductal gray after chemoreceptor and baroreceptor activation. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1975-H1984.
116. Hervieu G.J., Cluderay J.E., Harrison D.C., Roberts J.C., Leslie R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001, 103:777-797.
117. Hodges M.R., Richerson G.B. Medullary serotonin neurons and their roles in central respiratory chemoreception. Respir. Physiol. Neurobiol. 2010, 173:256-263.
118. Hollander E., Liebowitz M.R., Gorman J.M., Cohen B., Fyer A., Klein D.F. Cortisol and sodium lactate-induced panic. Arch. Gen. Psychiatry 1989, 46:135-140.
119. Hoyer D., Hannon J.P., Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 2002, 71:533-554.
120. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun. 2000, 270:318-323.
121. Jacob C.A., Cabral A.H., Almeida L.P., Magierek V., Ramos P.L., Zanoveli J.M., Landeira-Fernandez J., Zangrossi H., Nogueira R.L. Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray. Pharmacol. Biochem. Behav. 2002, 72:761-766.
122. Jansen A.S.P., Farkas E., Mac S.J., Loewy A.D. Local connections between the columns of the periaqueductal gray matter: a case for intrinsic neuromodulation. Brain research 784 (1998) 329-336. Brain Res. 1998, 797:368.
123. Jenck F., Moreau J.L., Martin J.R. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Res. 1995, 57:181-191.
124. Johnson P.L., Fitz S.D., Hollis J.H., Moratalla R., Lightman S.L., Shekhar A., Lowry C.A. Induction of c-Fos in 'panic/defence'-related brain circuits following brief hypercarbic gas exposure. J. Psychopharmacol. 2010, (Epub ahead of print).
125. Johnson P.L., Hollis J.H., Moratalla R., Lightman S.L., Lowry C.A. Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats. J. Psychopharmacol. 2005, 19:327-341.
126. Johnson P.L., Lightman S.L., Lowry C.A. A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann. N. Y. Acad. Sci. 2004, 1018:58-64.
127. Johnson P.L., Lowry C.A., Truitt W., Shekhar A. Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic. J. Psychopharmacol. 2008, 22:642-645.
128. Johnson P.L., Sajdyk T.J., Fitz S.D., Hale M.W., Lowry C.A., Hay-Schmidt A., Shekhar A. Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 44C:248-256.
129. Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., Traskman-Bendz L., Goddard A.W., Brundin L., Shekhar A. A key role for orexin in panic anxiety. Nat. Med. 2010, 16:111-115.
130. Johnson P.L., Truitt W.A., Fitz S.D., Lowry C.A., Shekhar A. Neural Pathways Underlying Lactate-Induced Panic. Neuropsychopharmacology 2007, 33:2093-2107.
131. Jokivarsi K.T., Hiltunen Y., Grohn H., Tuunanen P., Grohn O.H., Kauppinen R.A. Estimation of the onset time of cerebral ischemia using T1rho and T2 MRI in rats. Stroke 2010, 41:2335-2340.
132. Jones C.K., Schlosser M.J., van Zijl P.C., Pomper M.G., Golay X., Zhou J. Amide proton transfer imaging of human brain tumors at 3T. Magn. Reson. Med. 2006, 56:585-592.
133. Kapp B.S., Gallagher M., Underwood M.D., McNall C.L., Whitehorn D. Cardiovascular responses elicited by electrical stimulation of the amygdala central nucleus in the rabbit. Brain Res. 1982, 234:251-262.
134. Keay K.A., Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci. Biobehav. Rev. 2001, 25:669-678.
135. Kellner M. Experimental panic provocation in healthy man - a translational role in anti-panic drug development?. Dialog. Clin. Neurosci. 2011, 13:485-493.
136. Kellner M., Wiedemann K. Nonresponse of adrenocorticotropic hormone in first-ever lactate-induced panic attacks in healthy volunteers. Arch. Gen. Psychiatry 1998, 55:85-86.
137. Kerman I.A., Shabrang C., Taylor L., Akil H., Watson S.J. Relationship of presympathetic-premotor neurons to the serotonergic transmitter system in the rat brainstem. J. Comp. Neurol. 2006, 499:882-896.
138. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
139. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:617-627.
140. Kessler R.C., Chiu W.T., Jin R., Ruscio A.M., Shear K., Walters E.E. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2006, 63:415-424.
141. Kessler R.C., Petukhova M., Sampson N.A., Zaslavsky A.M., Wittchen H.U. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int. J. Methods Psychiatr. Res. 2012, 21:169-184.
142. Kilduff T.S., de Lecea L. Mapping of the mRNAs for the hypocretin/orexin and melanin-concentrating hormone receptors: networks of overlapping peptide systems. J. Comp. Neurol. 2001, 435:1-5.
143. Kim S.J., Park S.H., Choi S.H., Moon B.H., Lee K.J., Kang S.W., Lee M.S., Choi S.H., Chun B.G., Shin K.H. Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats. Neuropharmacology 2006, 50:824-833.
144. Kirby L.G., Rice K.C., Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 2000, 22:148-162.
145. Klein D.F. DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES. Psychopharmacologia 1964, 5:397-408.
146. Klein D.F. Response differences of spontaneous panic and fear. Arch. Gen. Psychiatry 2002, 59:567-569.
147. Klein D.F. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch. Gen. Psychiatry 1993, 50:306-317.
148. Klein R.G. Is panic disorder associated with childhood separation anxiety disorder?. Clin. Neuropharmacol. 1995, 18:S7-S14.
149. Koch M. The neurobiology of startle. Prog. Neurobiol. 1999, 59:107-128.
150. Kohler C., Steinbusch H. Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience 1982, 7:951-975.
151. 2+ transients mediated by L-type calcium channels. J. Neurophysiol. 2008, 100:2265-2281.
152. Koob G.F., Le M.M. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2008, 363:3113-3123.
153. Kuwaki T. Orexin links emotional stress to autonomic functions. Auton. Neurosci. 2011, 161:20-27.
154. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 1988, 8:2517-2529.
155. Lee H.S., Park S.H., Song W.C., Waterhouse B.D. Retrograde study of hypocretin-1 (orexin-A) projections to subdivisions of the dorsal raphe nucleus in the rat. Brain Res. 2005, 1059:35-45.
156. Lee Y., Fitz S., Johnson P.L., Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 2008, 33:2586-2594.
157. Levin A.P., Doran A.R., Liebowitz M.R., Fyer A.J., Gorman J.M., Klein D.F., Paul S.M. Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res. 1987, 21:23-32.
158. Lewis-Fernandez R., Hinton D.E., Laria A.J., Patterson E.H., Hofmann S.G., Craske M.G., Stein D.J., Asnaani A., Liao B. Culture and the anxiety disorders: recommendations for DSM-V. Depress. Anxiety 2010, 27:212-229.
159. Ley R. Dyspneic-fear and catastrophic cognitions in hyperventilatory panic attacks. Behav. Res. Ther. 1989, 27:549-554.
160. Ley R. Agoraphobia, the panic attack and the hyperventilation syndrome. Behav. Res. Ther. 1985, 23:79-81.
161. Ley R. The many faces of Pan: psychological and physiological differences among three types of panic attacks. Behav. Res. Ther. 1992, 30:347-357.
162. Li J., Hu Z., de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br. J. Pharmacol. 2014, 171:332-350.
163. Liebowitz M.R., Gorman J.M., Fyer A., Dillon D., Levitt M., Klein D.F. Possible mechanisms for lactate's induction of panic. Am. J. Psychiatry 1986, 143:495-502.
164. Liu R.J., Van Den Pol A.N., Aghajanian G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci. 2002, 22:9453-9464.
165. Lowry C.A., Hale M.W., Evans A.K., Heerkens J., Staub D.R., Gasser P.J., Shekhar A. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann. N. Y. Acad. Sci. 2008, 1148:86-94.
166. Lowry C.A., Hollis J.H., de V.A., Pan B., Brunet L.R., Hunt J.R., Paton J.F., van K.E., Knight D.M., Evans A.K., Rook G.A., Lightman S.L. Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience 2007, 146:756-772.
167. Lowry C.A., Rodda J.E., Lightman S.L., Ingram C.D. Corticotropin-releasing factor increases In vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J. Neurosci. 2000, 20:7728-7736.
168. Lukkes J.L., Forster G.L., Renner K.J., Summers C.H. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphe differentially affect serotonin release in the nucleus accumbens. Eur. J. Pharmacol. 2008, 578:185-193.
169. Lukkes J.L., Kopelman J.M., Donner N.C., Hale M.W., Lowry C.A. Development×environment interactions control tph2 mRNA expression. Neuroscience 2013.
170. Lukkes J.L., Staub D.R., Dietrich A., Truitt W., Neufeld-Cohen A., Chen A., Johnson P.L., Shekhar A., Lowry C.A. Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase. Neuroscience 2011, 183:47-63.
171. Lungwitz E.A., Molosh A., Johnson P.L., Harvey B.P., Dirks R.C., Dietrich A., Minick P., Shekhar A., Truitt W.A. Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiol. Behav. 2012, 107:726-732.
172. Maddock R.J., Buonocore M.H., Copeland L.E., Richards A.L. Elevated brain lactate responses to neural activation in panic disorder: a dynamic 1H-MRS study. Mol. Psychiatry 2009, 14:537-545.
173. Magnotta V.A., Heo H.Y., Dlouhy B.J., Dahdaleh N.S., Follmer R.L., Thedens D.R., Welsh M.J., Wemmie J.A. Detecting activity-evoked pH changes in human brain. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:8270-8273.
174. Makela H.I., Grohn O.H., Kettunen M.I., Kauppinen R.A. Proton exchange as a relaxation mechanism for T1 in the rotating frame in native and immobilized protein solutions. Biochem. Biophys. Res. Commun. 2001, 289:813-818.
175. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 2001, 435:6-25.
176. Martinez R.C., de Oliveira A.R., Brandao M.L. Conditioned and unconditioned fear organized in the periaqueductal gray are differentially sensitive to injections of muscimol into amygdaloid nuclei. Neurobiol. Learn. Mem. 2006, 85:58-65.
177. Masini C.V., Sauer S., Campeau S. Ferret odor as a processive stress model in rats: neurochemical, behavioral, and endocrine evidence. Behav. Neurosci. 2005, 119:280-292.
178. Masini C.V., Sauer S., White J., Day H.E., Campeau S. Non-associative defensive responses of rats to ferret odor. Physiol. Behav. 2006, 87:72-81.
179. McNaughton N., Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci. Biobehav. Rev. 2004, 28:285-305.
180. Mochcovitch M.D., Nardi A.E. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies. Expert Rev. Neurother. 2010, 10:1285-1293.
181. Moga M.M., Saper C.B., Gray T.S. Bed nucleus of the stria terminalis: cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat. J. Comp. Neurol. 1989, 283:315-332.
182. Mongeau R., Marsden C.A. Effect of central and peripheral administrations of cholecystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat. Biol. Psychiatry 1997, 42:335-344.
183. Mongeau R., Marsden C.A. Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats. Psychopharmacology (Berl.) 1997, 131:321-328.
184. Muraki Y., Yamanaka A., Tsujino N., Kilduff T.S., Goto K., Sakurai T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J. Neurosci. 2004, 24:7159-7166.
185. Nader K., Majidishad P., Amorapanth P., LeDoux J.E. Damage to the lateral and central, but not other, amygdaloid nuclei prevents the acquisition of auditory fear conditioning. Learn. Mem. 2001, 8:156-163.
186. Nakamura S., Tsumori T., Yokota S., Oka T., Yasui Y. Amygdaloid axons innervate melanin-concentrating hormone- and orexin-containing neurons in the mouse lateral hypothalamus. Brain Res. 2009, 1278:66-74.
187. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 1999, 827:243-260.
188. Nashold B.S., Wilson W.P., Slaughter D.G. Sensations evoked by stimulation in the midbrain of man. J. Neurosurg. 1969, 30:14-24.
189. Nesse R.M., Cameron O.G., Curtis G.C., McCann D.S., Huber-Smith M.J. Adrenergic function in patients with panic anxiety. Arch. Gen. Psychiatry 1984, 41:771-776.
190. Nierenberg A.A. Timing of onset of antidepressant response with fluoxetine treatment. Am. J. Psychiatry 2000.
191. Nogueira R.L., Graeff F.G. Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol. Biochem. Behav. 1995, 52:1-6.
192. Noyes R. Comorbidity in generalized anxiety disorder. Pediatr. Clin. North Am. 2001, 24:41-55.
193. Noyes R., Woodman C., Garvey M.J., Cook B.L., Suelzer M., Clancy J., Anderson D.J. Generalized anxiety disorder vs. panic disorder. Distinguishing characteristics and patterns of comorbidity. J. Nerv. Ment. Dis. 1992, 180:369-379.
194. Nutt D.J. Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr. 2005, 10:49-56.
195. Oka T., Tsumori T., Yokota S., Yasui Y. Neuroanatomical and neurochemical organization of projections from the central amygdaloid nucleus to the nucleus retroambiguus via the periaqueductal gray in the rat. Neurosci. Res. 2008, 62:286-298.
196. Paul E.D., Hale M.W., Lukkes J.L., Valentine M.J., Sarchet D.M., Lowry C.A. Repeated social defeat increases reactive emotional coping behavior and alters functional responses in serotonergic neurons in the rat dorsal raphe nucleus. Physiol. Behav. 2011, 104:272-282.
197. Paul E.D., Lowry C.A. Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders. J. Psychopharmacol. 2013, 27:1090-1106.
198. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego. 4th ed.
199. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., Valentino R.J. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci. 2004, 24:1305-1311.
200. Peskind E.R., Jensen C.F., Pascualy M., Tsuang D., Cowley D., Martin D.C., Wilkinson C.W., Raskind M.A. Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder. Biol. Psychiatry 1998, 44:1007-1016.
201. Petrovich G.D., Swanson L.W. Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res. 1997, 763:247-254.
202. Peyron C., Petit J.-M., Rampon C., Jouvet M., Luppi P.-H. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 1998, 82:443-468.
203. Peyron C., Tighe D.K., Van Den Pol A.N., de L.L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
204. Pitts F.N., McClure J.N. Lactate metabolism in anxiety neurosis. N. Engl. J. Med. 1967, 277:1329-1336.
205. Pobbe R.L., Zangrossi H. 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacology (Berl.) 2005, 183:314-321.
206. Pobbe R.L., Zangrossi H., Blanchard D.C., Blanchard R.J. Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors. Eur. Neuropsychopharmacol. 2011, 21:306-315.
207. Porrino L.J., Goldman-Rakic P.S. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J. Comp. Neurol. 1982, 205:63-76.
208. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8777-8781.
209. Preter M., Klein D.F. Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:603-612.
210. Rainey J.M., Pohl R.B., Williams M., Knitter E., Freedman R.R., Ettedgui E. A comparison of lactate and isoproterenol anxiety states. Psychopathology 1984, 17(Suppl. 1):74-82.
211. Ray R.S., Corcoran A.E., Brust R.D., Kim J.C., Richerson G.B., Nattie E., Dymecki S.M. Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition. Science 2011, 333:637-642.
212. Reiman E.M., Raichle M.E., Robins E., Mintun M.A., Fusselman M.J., Fox P.T., Price J.L., Hackman K.A. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch. Gen. Psychiatry 1989, 46:493-500.
213. Reyes T.M., Walker J.R., DeCino C., Hogenesch J.B., Sawchenko P.E. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J. Neurosci. 2003, 23:5607-5616.
214. Richerson G.B. Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat. Rev. Neurosci. 2004, 5:449-461.
215. Rizvi T.A., Ennis M., Behbehani M.M., Shipley M.T. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J. Comp. Neurol. 1991, 303:121-131.
216. Rosen J.B., Schulkin J. From normal fear to pathological anxiety. Psychol. Rev. 1998, 105:325-350.
217. Rozeske R.R., Evans A.K., Frank M.G., Watkins L.R., Lowry C.A., Maier S.F. Uncontrollable, but not controllable, stress desensitizes 5-HT1A receptors in the dorsal raphe nucleus. J. Neurosci. 2011, 31:14107-14115.
218. Sajdyk T., Johnson P., Fitz S., Shekhar A. Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior. J. Psychopharmacol. 2008, 22:633-641.
219. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav. Brain Res. 1999, 100:207-215.
220. Sakamoto F., Yamada S., Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept. 2004, 118:183-191.
221. Sakanaka M., Shibasaki T., Lederis K. Distribution of efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 1986, 382:213-238.
222. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 2007, 8:171-181.
223. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
224. Sakurai T., Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol. Sci. 2011, 32:451-462.
225. Sakurai T., Nagata R., Yamanaka A., Kawamura H., Tsujino N., Muraki Y., Kageyama H., Kunita S., Takahashi S., Goto K., Koyama Y., Shioda S., Yanagisawa M. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005, 46:297-308.
226. Sandner G., Schmitt P., Karli P. Mapping of jumping, rearing, squealing and switch-off behaviors elicited by periaqueductal gray stimulation in the rat. Physiol. Behav. 1987, 39:333-339.
227. Schenberg L.C., Bittencourt A.S., Sudre E.C., Vargas L.C. Modeling panic attacks. Neurosci. Biobehav. Rev. 2001, 25:647-659.
228. Schenberg L.C., Dos Reis A.M., Ferreira Povoa R.M., Tufik S., Silva S.R. A panic attack-like unusual stress reaction. Horm. Behav. 2008, 54:584-591.
229. Schenberg L.C., Vasquez E.C., da Costa M.B. Cardiac baroreflex dynamics during the defence reaction in freely moving rats. Brain Res. 1993, 621:50-58.
230. Schimitel F.G., de Almeida G.M., Pitol D.N., Armini R.S., Tufik S., Schenberg L.C. Evidence of a suffocation alarm system within the periaqueductal gray matter of the rat. Neuroscience 2012, 200:59-73.
231. Schneier F.R. Fluoxetine in panic disorder. J. Clin. Psychopharmacol. 1990.
232. Sela V.R., Biesdorf C., Ramos D.H., Zangrossi H., Graeff F.G., Audi E.A. Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze. Neurosci. Lett. 2011, 495:63-66.
233. Sellayah D., Sikder D. Food for thought: understanding the multifaceted nature of orexins. Endocrinology 2013, 154:3990-3999.
234. Severson C.A., Wang W., Pieribone V.A., Dohle C.I., Richerson G.B. Midbrain serotonergic neurons are central pH chemoreceptors. Nat. Neurosci. 2003, 6:1139-1140.
235. Shekhar A., Johnson P.L., Sajdyk T.J., Fitz S.D., Keim S.R., Kelley P.E., Gehlert D.R., DiMicco J.A. Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus. J. Neurosci. 2006, 26:9205-9215.
236. Shekhar A., Keim S.R. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J. Neurosci. 1997, 17:9726-9735.
237. Shekhar A., Keim S.R., Simon J.R., McBride W.J. Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions. Pharmacol. Biochem. Behav. 1996, 55:249-256.
238. Simon N.M., Fischmann D. The implications of medical and psychiatric comorbidity with panic disorder. J. Clin. Psychiatry 2005, 66(Suppl. 4):8-15.
239. Sinha S., Papp L.A., Gorman J.M. How study of respiratory physiology aided our understanding of abnormal brain function in panic disorder. J. Affect. Disord. 2000, 61:191-200.
240. Sink K.S., Walker D.L., Freeman S.M., Flandreau E.I., Ressler K.J., Davis M. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Mol. Psychiatry 2013, 18:308-319.
241. Spannuth B.M., Hale M.W., Evans A.K., Lukkes J.L., Campeau S., Lowry C.A. Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle. Neuroscience 2011.
242. Staub D.R., Evans A.K., Lowry C.A. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF(2)) receptors in the regulation of subpopulations of serotonergic neurons. Brain Res. 2006, 1070:77-89.
243. Staub D.R., Spiga F., Lowry C.A. Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus. Brain Res. 2005, 1044:176-189.
244. Stezhka V.V., Lovick T.A. Projections from dorsal raphe nucleus to the periaqueductal grey matter: studies in slices of rat midbrain maintained in vitro. Neurosci. Lett. 1997, 230:57-60.
245. Stezhka V.V., Lovick T.A. Inhibitory and excitatory projections from the dorsal raphe nucleus to neurons in the dorsolateral periaqueductal gray matter in slices of midbrain maintained in vitro. Neuroscience 1994, 62:177-187.
246. Takahashi K., Wang Q.P., Guan J.L., Kayama Y., Shioda S., Koyama Y. State-dependent effects of orexins on the serotonergic dorsal raphe neurons in the rat. Regul. Pept. 2005, 126:43-47.
247. + channel, is modulated by multiple neurotransmitters in motoneurons. Neuron 2000, 25:399-410.
248. Tannure R.M., Bittencourt A.S., Schenberg L.C. Short-term full kindling of the amygdala dissociates natural and periaqueductal gray-evoked flight behaviors of the rat. Behav. Brain Res. 2009, 199:247-256.
249. Tao R., Ma Z., McKenna J.T., Thakkar M.M., Winston S., Strecker R.E., McCarley R.W. Differential effect of orexins (hypocretins) on serotonin release in the dorsal and median raphe nuclei of freely behaving rats. Neuroscience 2006, 141:1101-1105.
250. Targum S.D., Marshall L.E. Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res. 1989, 28:295-306.
251. Teppema L.J., Veening J.G., Kranenburg A., Dahan A., Berkenbosch A., Olievier C. Expression of c-fos in the rat brainstem after exposure to hypoxia and to normoxic and hyperoxic hypercapnia. J. Comp. Neurol. 1997, 388:169-190.
252. Thornton H.B., Nel D., Thornton D., van H.J., Baker G.A., Stein D.J. The neuropsychiatry and neuropsychology of lipoid proteinosis. J. Neuropsychiatry Clin. Neurosci. 2008, 20:86-92.
253. Trivedi P., Yu H., MacNeil D.J., Van der Ploeg L.H., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998, 438:71-75.
254. Tsujino N., Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front. Behav. Neurosci. 2013, 7:28.
255. Valentino R.J., Liouterman L., Van Bockstaele E.J. Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J. Comp. Neurol. 2001, 435:450-463.
256. van der Wee N.J., Fiselier J., van Megen H.J., Westenberg H.G. Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls. Eur. Neuropsychopharmacol. 2004, 14:413-417.
257. van Veen J.F., van der Wee N.J., Fiselier J., van V.I., Westenberg H.G. Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls. Eur. Neuropsychopharmacol. 2007, 17:637-642.
258. Vargas L.C., Schenberg L.C. Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat. Psychopharmacology (Berl.) 2001, 155:260-268.
259. Veasey S.C., Fornal C.A., Metzler C.W., Jacobs B.L. Single-unit responses of serotonergic dorsal raphe neurons to specific motor challenges in freely moving cats. Neuroscience 1997, 79:161-169.
260. Veasey S.C., Fornal C.A., Metzler C.W., Jacobs B.L. Response of serotonergic caudal raphe neurons in relation to specific motor activities in freely moving cats. J. Neurosci. 1995, 15:5346-5359.
261. Veening J.G., Swanson L.W., Sawchenko P.E. The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Res. 1984, 303:337-357.
262. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 1991, 313:643-668.
263. Viana M.B., Graeff F.G., Loschmann P.A. Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray. Pharmacol. Biochem. Behav. 1997, 58:167-172.
264. Vianna D.M., Brandao M.L. Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear. Braz. J. Med. Biol. Res. 2003, 36:557-566.
265. Walker D.L., Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J. Neurosci. 1997, 17:9375-9383.
266. Walker D.L., Toufexis D.J., Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur. J. Pharmacol. 2003, 463:199-216.
267. Wang L., Goebel-Stengel M., Stengel A., Wu S.V., Ohning G., Tache Y. Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery. Brain Res. 2011, 1415:34-46.
268. Wang Q.P., Koyama Y., Guan J.L., Takahashi K., Kayama Y., Shioda S. The orexinergic synaptic innervation of serotonin- and orexin 1-receptor-containing neurons in the dorsal raphe nucleus. Regul. Pept. 2005, 126:35-42.
269. Wang S., Benamer N., Zanella S., Kumar N.N., Shi Y., Bevengut M., Penton D., Guyenet P.G., Lesage F., Gestreau C., Barhanin J., Bayliss D.A. TASK-2 channels contribute to pH sensitivity of retrotrapezoid nucleus chemoreceptor neurons. J. Neurosci. 2013, 33:16033-16044.
270. Wang W., Tiwari J.K., Bradley S.R., Zaykin R.V., Richerson G.B. Acidosis-stimulated neurons of the medullary raphe are serotonergic. J. Neurophysiol. 2001, 85:2224-2235.
271. + conductance. J. Neurosci. 2002, 22:1256-1265.
272. Watanabe S., Kuwaki T., Yanagisawa M., Fukuda Y., Shimoyama M. Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport 2005, 16:5-8.
273. + channel TASK-3 coupled to 5-HT2C receptors. Eur. J. Neurol. 2008, 28:931-940.
274. Wemmie J.A., Coryell M.W., Askwith C.C., Lamani E., Leonard A.S., Sigmund C.D., Welsh M.J. Overexpression of acid-sensing ion channel 1a in transgenic mice increases acquired fear-related behavior. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3621-3626.
275. Winsky-Sommerer R., Boutrel B., de L.L. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol. Neurobiol. 2005, 32:285-294.
276. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de L.L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 2004, 24:11439-11448.
277. Woods S.W., Charney D.S., Goodman W.K., Heninger G.R. Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch. Gen. Psychiatry 1988, 45:43-52.
278. Yamanaka A., Muraki Y., Tsujino N., Goto K., Sakurai T. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem. Biophys. Res. Commun. 2003, 303:120-129.
279. Yamashita P.S., de Bortoli V.C., Zangrossi H. 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray. Neuropharmacology 2011, 60:216-222.
280. Yeomans J.S., Li L., Scott B.W., Frankland P.W. Tactile, acoustic and vestibular systems sum to elicit the startle reflex. Neurosci. Biobehav. Rev. 2002, 26:1-11.
281. Yoshida K., McCormack S., Espana R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 2006, 494:845-861.
282. Zanoveli J.M., Nogueira R.L., Zangrossi H. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. Behav. Pharmacol. 2005, 16:543-552.
283. Zanoveli J.M., Nogueira R.L., Zangrossi H. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology 2007, 52:1188-1195.
284. Zanoveli J.M., Pobbe R.L., de Bortoli V.C., Carvalho M.C., Brandao M.L., Zangrossi H. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine. Int. J. Neuropsychopharmacol. 2010, 13:1079-1088.
285. Zhang W., Shimoyama M., Fukuda Y., Kuwaki T. Multiple components of the defense response depend on orexin: evidence from orexin knockout mice and orexin neuron-ablated mice. Auton. Neurosci. 2006, 126-127:139-145.
286. Zhou J., Payen J.F., Wilson D.A., Traystman R.J., van Zijl P.C. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat. Med. 2003, 9:1085-1090.
287. Zhu L., Onaka T., Sakurai T., Yada T. Activation of orexin neurones after noxious but not conditioned fear stimuli in rats. Neuroreport 2002, 13:1351-1353.
288. Ziemann A.E., Allen J.E., Dahdaleh N.S., Drebot I.I., Coryell M.W., Wunsch A.M., Lynch C.M., Faraci F.M., Howard M.A., Welsh M.J., Wemmie J.A. The amygdala is a chemosensor that detects carbon dioxide and acidosis to elicit fear behavior. Cell 2009, 139:1012-1021.